Ascendis Pharma A/S

ASNDNasdaq Denmark Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$15.830 B

$255.41 +2.23%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

61,977,408

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#25Jazz PharmaceuticalsJAZZ$16.7B
#26BridgeBio PharmaBBIO$16.5B
#27Ascendis Pharma A/SASND$15.8B
#28Arrowhead PharmaceuticalsARWR$12.4B
#29Biomarin PharmaceuticalBMRN$12.3B

Where these numbers come from

Share counts and financials for Ascendis Pharma A/S are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.